Search:
		Recent Clinical Trials: CHAMPIONS and BENEFIT Investigators Discuss Their Studies Sponsored by the Postgraduate Institute for Medicine Release date: April 2007 Expiration date: April 2008 Estimated time to complete activity: 1 hour This educational program is supported through an educational grant from Biogen IDEC and Elan Pharmaceuticals Inc. MS is often heralded by a single demyelinating event known as clinically isolated syndrome. Patients who present with CIS along with evidence of subclinical disease activity on MRI are at a higher risk of developing clinically definite MS than patients who have normal results on MRI. Early treatment with beta interferon has become a standard of care for these patients. This program will discuss the three interferon therapies approved for MS and the clinical trials that support their use following a single demyelinating event. Windows Me / XP / 2000. 800 MHz P4 processor. 256 MB RAM. Microsoft Internet Explorer 5.5 or greater and Mozilla Firefox Additional Requirements: Flash player 9.0 or greater 800x600 Resolution or Higher with 32-bit color Connection Speed: 128 Kbps or better Adobe Acrobat 6.0 or greater. Click here to review the complete CME information.
	Resources  |  About Us  |  Contact Us  |  Privacy Policy  |  Disclaimer  |  Editorial & Sponsorship Policy  |  Terms of Use Search: